IIT Delhi team develops a new antibacterial drug-delivery system
7th
August:
The
nanoconjugates will be useful for cancer patients suffering from bacterial
infections. A new antibiotic drug-delivery system that
improves the efficacy of drugs thereby reducing the dosage used for treating
bacterial infections has been tested in a lab by researchers at the Indian
Institute of Technology (IIT) Delhi.
Drug delivery
becomes better and the bioavailability improves when the drug is conjugated
[bound] to gold nanoparticles. So reduced dosage is sufficient to kill the
bacteria. Reducing the dosage of antibiotics used is one of the strategies to
reduce the possibility of drug resistance setting in.
ટિપ્પણીઓ નથી:
ટિપ્પણી પોસ્ટ કરો